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Targeting toll-like receptor 7/8 
improves host anti-infective response in 
alcoholic cirrhosis
Emanuele Albano,1 Felix Stickel2
The production of reactive oxygen species 
(ROS) by activated macrophages and 
neutrophil granulocytes represents an 
important cause of alcohol-induced oxida-
tive stress and significantly contributes to 
the pathogenesis of alcoholic liver disease 
(ALD).1 Furthermore, diffuse neutrophil 
infiltration of the liver is a key feature of 
acute alcoholic hepatitis actively partici-
pating to parenchymal injury.2 However, 
during ALD progression to cirrhosis, 
neutrophil functions such as ROS produc-
tion, bacterial phagocytosis and granule 
exocytosis are impaired leading to an 
increased susceptibility to bacterial infec-
tions of cirrhotic patients.3 Indeed, the 
development of bacterial peritonitis is a 
common complication of cirrhosis, while 
sepsis is a major cause of mortality in 
patients with decompensated alcoholic 
cirrhosis being also associated with multi-
organ failure and immune deficiencies.4
The key role of neutrophils in anti-
bacterial defences mainly relies on the 
capacity of the enzyme NADPH oxidase 
2 (NOX2) to generate superoxide anion 
(O2
−) during a process known as oxidative 
burst. Superoxide anion, in fact, by conver-
sion to hydrogen peroxide, fuels myelop-
eroxidase-mediated production of the 
powerful bactericidal agents, hypochlorite 
and chloramine.5 NOX2 is a multiprotein 
enzymatic system consisting of the trans-
membrane proteins gp91phox and p22phox 
forming the catalytic unit flavocytochrome 
b558 and of several cytosolic components, 
including the p67phox, p47phox, p40phox and 
Rac1/2 subunits.5 On phosphorylation of 
p47phox, the different subunits assemble to 
the plasma membrane forming the active 
enzyme. Thus, an efficient ROS production 
requires an optimal expression of all the 
NOX2 components and coordinated signals 
driving the enzyme assembly.5
In Gut, Rolas et al6 add further 
insights into the mechanisms responsible 
for the deficit in neutrophils’ bacteri-
cidal activity that characterises alcoholic 
cirrhosis by investigating some of the 
mechanisms responsible for the impair-
ment of ROS production by NOX2. They 
report that the deficiency in oxidative 
burst that characterises the response to 
formylated peptides of neutrophils from 
decompensated cirrhotic patients was 
associated with a severe reduction in the 
intracellular content of gp91phox, p22phox 
and p47phox, despite their unchanged 
messenger RNA levels. By investigating 
the mechanisms involved, they observed 
that the decrease of gp91phox was partially 
due to an enhanced protein degradation 
due to elastase released by neutrophils 
themselves and more abundant in the 
plasma of cirrhotic patients. In addi-
tion, the lowering of NOX2 components 
also involved an impairment of protein 
synthesis consequent to the reduc-
tion of the kinase mammalian target of 
rapamycin (mTOR), a key regulator of 
cellular anabolic processes. Interestingly, 
treating the neutrophils from cirrhotic 
patients with the Toll-like receptor 
(TLR) 7/8 agonists CL097 and R848 
restored ROS production by stimulating 
the synthesis of NOX2 components 
through a process involving mTOR acti-
vation. TLR-7/8 agonists were also active 
when added to whole blood, while the 
use of the elastase inhibitor N-(methoxy-
succinyl)-Ala-Ala-Pro-Val-chloromethyl-
ketone had a minimal impact on NOX2 
recovery. The effect of TLR agonists was 
rather specific, as the TLR-4 stimulation 
by lipopolysaccharide enhanced gp91phox 
expression but modestly improved 
ROS production. Such a specificity 
might likely relate to the capacity of 
TLR-7/8-mediated signals to potentiate 
NOX2 activity through the phosphoryla-
tion of p47phox by protein kinase B (AKT), 
mTOR and p38 mitogen-activated kinase 
(p38MAPK)7 (figure 1). From these data, 
the authors conclude that elastase-depen-
dent degradation and mTOR impairment 
contribute to the decrease gp91phox and 
ROS production observed in patients 
with alcoholic cirrhosis. However, the 
latter process appears be more relevant 
to explain the defect in ROS production, 
as protein synthesis can compensate for 
the loss of gp91phox due to elastase-me-
diated degradation. A deficit of gp91phox 
also accounts for the lowering in 
ROS-mediated bacterial killing by mono-
cytes of patients with alcoholic hepa-
titis,8 indicating that in alcohol abusers, 
similar mechanisms can be responsible 
for affecting the functions of different 
phagocytic cells. Interestingly, TLR-7/8 
stimulation of AKT/mTOR also contrib-
utes to restore neutrophil’s bactericidal 
activity by promoting myeloperoxidase 
release9 (figure 1). Nonetheless, several 
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Figure 1 Proposed mechanisms by which TLR-7/8 stimulation improves the antibacterial 
activity of neutrophils from patients with alcoholic cirrhosis. AKT, protein kinase B; H2O2, 
hydrogen peroxide; HClO, hypochlorous acid; MPO, myeloperoxidase; mTOR, mammalian target 
of rapamycin; NOX2, NADPH oxidase 2; O2
−, superoxide anion; p38MAPK, p38 mitogen-activated 
kinase; TLR-7/8 Toll-like receptor-7/8; gp91phox, p22phox p67phox, p47phox, p40phox, Rac1/2 NOX2 
subunits.
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issues remain still open. For instance, 
little is known about the mechanisms 
that lead to the lowering of neutro-
phil mTOR in advanced ALD, and it is 
still unclear how TLR-7/8 stimulation 
acts in reverting mTOR activity. On 
the other hand, the presented data add 
to the consensus that mTOR inhibitors 
are most likely ill advised as antifibrotic 
treatment in advanced liver fibrosis, as 
they will inevitably worsen the defective 
oxidative burst of neutrophils and thus 
increase the risk of infections.
In conclusion, this work nicely 
supports previous data from the same 
group pointing to a key role of AKT/
mTOR in the mechanisms affecting the 
bactericidal activity of neutrophils in 
alcoholic cirrhosis.7 9 The significance 
of the presented data mainly derives 
from its possible clinical translation into 
using TLR-7/8 agonists to reverse alco-
hol-mediated impairment of neutrophil 
ROS production and thus improve the 
host’s antibacterial defence of patients 
with alcoholic (and non-alcoholic?) 
cirrhosis. Whether this could be imple-
mented in a treatment of established 
infections or in their prevention remains 
to be determined. However, as a novel 
therapeutic target, TLRs clearly deserve 
further investigation in humans, partic-
ularly since prophylactic antibiotic treat-
ment in patients with cirrhosis achieves 
only a moderate benefit.10 In this regard, 
it seems important to emphasise that TLR 
agonists have been shown to be effective 
in promoting both innate and adaptive 
immunity,11 and their use might exert a 
synergistic therapeutic effect with that of 
granulocyte colony-stimulating factor12 
in controlling infective complications of 
advanced ALD.
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